157
Views
50
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis

, PhD , MD, , , , &
Pages 1090-1094 | Received 05 Nov 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Einar S. Björnsson & Evangelos Kalaitzakis. (2021) Recent advances in the treatment of primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 15:4, pages 413-425.
Read now
Erik Schrumpf, Kirsten Muri Boberg & Tom H. Karlsen. (2015) Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 50:6, pages 781-796.
Read now
James H. Tabibian, Steven P. O’Hara & Keith D. Lindor. (2014) Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scandinavian Journal of Gastroenterology 49:8, pages 901-908.
Read now
James H Tabibian & Keith D Lindor. (2013) Primary sclerosing cholangitis: a review and update on therapeutic developments. Expert Review of Gastroenterology & Hepatology 7:2, pages 103-114.
Read now

Articles from other publishers (46)

Kim N. van Munster, Annika Bergquist & Cyriel Y. Ponsioen. (2024) Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?. Journal of Hepatology 80:1, pages 155-168.
Crossref
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi & Johannes R. Hov. (2023) Role of microbiome in autoimmune liver diseases. Hepatology.
Crossref
Johannes R. Hov & Tom H. Karlsen. (2022) The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 20:3, pages 135-154.
Crossref
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke & Michael Sigal. (2021) The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. International Journal of Molecular Sciences 22:13, pages 6975.
Crossref
Andreas Blesl & Vanessa Stadlbauer. (2021) The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 13:3, pages 1018.
Crossref
Ramon V. Cortez, Luana N. Moreira, Marina Padilha, Mariana D. Bibas, Ricardo K. Toma, Gilda Porta & Carla R. Taddei. (2021) Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Frontiers in Immunology 11.
Crossref
Vandana Jain, Emma C. Alexander, Charlotte Burford, Anita Verma & Anil Dhawan. (2021) Gut Microbiome. Journal of Pediatric Gastroenterology and Nutrition 72:2, pages 184-193.
Crossref
Lakshya Sharma & Antonio Riva. (2020) Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?. Microorganisms 8:11, pages 1744.
Crossref
Gregory Dean, Stephen Hanauer & Josh Levitsky. (2020) The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications. Hepatology 72:3, pages 1127-1138.
Crossref
Naiara Beraza. (2019) Fibrosis and the intestinal microbiome; a focus on chronic liver disease. Current Opinion in Pharmacology 49, pages 76-81.
Crossref
Sridhar Sundaram & Vaneet Jearth. (2019) Primary Sclerosing Cholangitis: A Clinical Update. European Medical Journal, pages 101-110.
Crossref
Michael Camilleri. (2019) Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 68:8, pages 1516-1526.
Crossref
Annika E. Langeneckert, Sebastian Lunemann, Glòria Martrus, Wilhelm Salzberger, Leonard U. Hess, Annerose E. Ziegler, Tobias Poch, Gevitha Ravichandran, Urte Matschl, Jens B. Bosse, Gisa Tiegs, Lutz Fischer, Martina Koch, Johannes Herkel, Karl J. Oldhafer, Christoph Schramm & Marcus Altfeld. (2019) CCL21‐expression and accumulation of CCR7 + NK cells in livers of patients with primary sclerosing cholangitis . European Journal of Immunology 49:5, pages 758-769.
Crossref
Amandeep K. Dhillon, Martin Kummen, Marius Trøseid, Sissel Åkra, Evaggelia Liaskou, Bjørn Moum, Mette Vesterhus, Tom H. Karlsen, Ingebjørg Seljeflot & Johannes R. Hov. (2018) Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis. Liver International 39:2, pages 371-381.
Crossref
Trevor J Laborda, M Kyle Jensen, Marianne Kavan & Mark Deneau. (2019) Treatment of primary sclerosing cholangitis in children. World Journal of Hepatology 11:1, pages 19-36.
Crossref
Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Masato Yoneda, Satoru Saito & Atsushi Nakajima. 2019. Alcoholic/Non-Alcoholic Digestive Diseases. Alcoholic/Non-Alcoholic Digestive Diseases 103 111 .
Tom Hemming Karlsen & Kirsten Muri Boberg. 2018. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System 341 354 .
Dirkjan Schokker, Jan Fledderus, Rutger Jansen, Stephanie A Vastenhouw, Freddy M de Bree, Mari A Smits & Alfons A J M Jansman. (2018) Supplementation of fructooligosaccharides to suckling piglets affects intestinal microbiota colonization and immune development1. Journal of Animal Science 96:6, pages 2139-2153.
Crossref
Tobias J. Weismüller & Christian P. Strassburg. (2018) Primär sklerosierende CholangitisPrimary sclerosing cholangitis. Der Gastroenterologe 13:3, pages 180-188.
Crossref
Christopher Bowlus, David N. Assis & David Goldberg. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 626 647.e6 .
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn & Mette Vesterhus. (2017) Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 67:6, pages 1298-1323.
Crossref
Ken Liu, Ruoxi Wang, Viraj Kariyawasam, Mark Wells, Simone I. Strasser, Geoff McCaughan, Crispin Corte & Rupert W. Leong. (2017) Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver International 37:3, pages 442-448.
Crossref
Baohong Wang, Mingfei Yao, Longxian Lv, Zongxin Ling & Lanjuan Li. (2017) The Human Microbiota in Health and Disease. Engineering 3:1, pages 71-82.
Crossref
Tamas Tornai, Eszter Palyu, Zsuzsanna Vitalis, Istvan Tornai, David Tornai, Peter Antal-Szalmas, Gary L Norman, Zakera Shums, Gabor Veres, Antal Dezsofi, Gabriella Par, Alajos Par, Peter Orosz, Ferenc Szalay, Peter Laszlo Lakatos & Maria Papp. (2017) Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. World Journal of Gastroenterology 23:29, pages 5412.
Crossref
Julian R Marchesi, David H Adams, Francesca Fava, Gerben D A Hermes, Gideon M Hirschfield, Georgina Hold, Mohammed Nabil Quraishi, James Kinross, Hauke Smidt, Kieran M Tuohy, Linda V Thomas, Erwin G Zoetendal & Ailsa Hart. (2016) The gut microbiota and host health: a new clinical frontier. Gut 65:2, pages 330-339.
Crossref
Kathleen Lange, Martin Buerger, Andreas Stallmach & Tony Bruns. (2016) Effects of Antibiotics on Gut Microbiota. Digestive Diseases 34:3, pages 260-268.
Crossref
Jayant A. Talwalkar & Konstantinos N. Lazaridis. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1835 1847 .
Luca Maroni, Stan F. J. van de Graaf, Simon D. Hohenester, Ronald P. J. Oude Elferink & Ulrich Beuers. (2014) Fucosyltransferase 2: A Genetic Risk Factor for Primary Sclerosing Cholangitis and Crohn's Disease—A Comprehensive Review. Clinical Reviews in Allergy & Immunology 48:2-3, pages 182-191.
Crossref
Christian Rupp, Konrad Alexander Bode, Fadi Chahoud, Andreas Wannhoff, Kilian Friedrich, Karl-Heinz Weiss, Peter Sauer, Wolfgang Stremmel & Daniel Nils Gotthardt. (2014) Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis. BMC Infectious Diseases 14:1.
Crossref
Harald Hofer, Emina Halilbasic, Katharina Staufer & Michael Trauner. 2014. Liver Immunology. Liver Immunology 301 316 .
Chalermrat Bunchorntavakul & K. Rajender Reddy. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 439 456 .
Palak J. Trivedi & David H. Adams. (2013) Mucosal immunity in liver autoimmunity: A comprehensive review. Journal of Autoimmunity 46, pages 97-111.
Crossref
J. H. Tabibian, E. Weeding, R. A. Jorgensen, J. L. Petz, J. C. Keach, J. A. Talwalkar & K. D. Lindor. (2013) Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study. Alimentary Pharmacology & Therapeutics 37:6, pages 604-612.
Crossref
James H. Tabibian, Jayant A. Talwalkar & Keith D. Lindor. (2013) Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis. BioMed Research International 2013, pages 1-7.
Crossref
Jing Hieng Ngu, Richard Blair Gearry, Andrew Jeffrey Wright & Catherine Ann Malcolm Stedman. (2011) Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 9:12, pages 1092-1097.
Crossref
Marion J. Pollheimer, Emina Halilbasic, Peter Fickert & Michael Trauner. (2011) Pathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 25:6, pages 727-739.
Crossref
Christopher L. Bowlus. (2010) Cutting Edge Issues in Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 41:2, pages 139-150.
Crossref
Nishchay Chandra, Susan N Cullen & Roger W Chapman. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 533 553 .
Jonathan H. Aron & Christopher L. Bowlus. (2009) The immunobiology of primary sclerosing cholangitis. Seminars in Immunopathology 31:3, pages 383-397.
Crossref
Angèle P. M. Kerckhoffs, Maarten R. Visser, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, Wil Harmsen & Louis M. A. Akkermans. (2008) Critical Evaluation of Diagnosing Bacterial Overgrowth in the Proximal Small Intestine. Journal of Clinical Gastroenterology 42:10, pages 1095-1102.
Crossref
Mariben R. Geonzon-Gonzales. (2008) Primary Sclerosing Cholangitis. Gastroenterology Nursing 31:2, pages 10-13.
Crossref
Tobias J. Weismüller, Jochen Wedemeyer, Stefan Kubicka, Christian P. Strassburg & Michael P. Manns. (2008) The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy. Journal of Hepatology 48, pages S38-S57.
Crossref
Peter B Soeters, Misha D Luyer, Jan Willem M Greve & Wim A Buurman. (2007) The significance of bowel permeability. Current Opinion in Clinical Nutrition and Metabolic Care 10:5, pages 632-638.
Crossref
Mariben R. Geonzon-Gonzales. (2007) Primary Sclerosing Cholangitis. Gastroenterology Nursing 30:2, pages 102-105.
Crossref
Sue Cullen & Roger Chapman. 2007. Liver Immunology. Liver Immunology 249 261 .
George R MacFaul & Roger W Chapman. (2006) Sclerosing cholangitis. Current Opinion in Gastroenterology 22:3, pages 288-293.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.